North America Archives - Page 28 of 39 - Journal for Clinical Studies

Current Edition

North America

7th International Conference on Clinical Trials

7th International Conference on Clinical Trials is scheduled to be held during September 24-26, 2018 at Chicago, USA. This Clinical Trials Conference includes a wide...

20 June 2018 North America 7th | clinical

Continue Reading →

Europe

Epsom and St Helier staff celebrate International Clinical Trials Day

Staff and researchers celebrated the healthcare advances made possible by clinical research at Epsom and St Helier Hospitals for this year’s International Clinical Tr...

13 June 2018 Europe | North America celebrate | clinical

Continue Reading →

Europe

New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma

Patients treated with cemiplimab experienced robust anti-tumor effects Data also presented today at the 2018 ASCO Annual Meeting Cemiplimab applications unde...

6 June 2018 Europe | North America anti-PD-1 | anti-tumour

Continue Reading →

Europe

Trump signs Right to Try Act for terminally ill patients

Nine-year-old Jordan McLinn, who has muscular dystrophy, shook Mr Trump's hand President Donald Trump has sig...

31 May 2018 Europe | North America act | ill

Continue Reading →

Europe

Researchers Develop Diagnostic for Rare Cancer-Generated Glycoproteins

Engineered chemical trap detects rare glycoproteins emitted as cancer first develops. Researchers at the Georgia Institute of Technology have designed a boronic acid ...

23 May 2018 Europe | North America cancer | diagnostic

Continue Reading →

North America

Rapid Medical initiates TIGER Clinical Study

Data from the study will be submitted to the FDA in support of Market Clearance for TIGERTRIEVER in the U.S. Rapid Medical, an Israeli company focused on the develo...

23 May 2018 North America clinical | initiation

Continue Reading →

Asia Pacific

Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate and Active Vitamin D in Children with X-Linked Hypophosphatemia (XLH)

Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients Receiving Conventional Therapy at 40 Weeks Ultragenyx Phar...

23 May 2018 Asia Pacific | Europe | North America Kirin | Kyowa

Continue Reading →

Europe

New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma

Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with ...

23 May 2018 Europe | North America Duxipient | England

Continue Reading →

North America

XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis

First Patient Begins Therapy with MABp1 for Treatment of Atopic Dermatitis XBiotech Inc. (NASDAQ:XBIT) announced today that the first patient has been enrolled in it...

23 May 2018 North America MABp1 | patient

Continue Reading →

Europe

US researchers develop tool to improve diagnostic accuracy

The tool has been used to analyse protein variation in diabetes, cancer, cardiovascular disease, neuro and retinal degeneration. A research team at the University at...

16 May 2018 Europe | North America accuracy | develop

Continue Reading →